Related Experiment Video
Updated: May 21, 2025

Electrophoretic Mobility Shift Assay EMSA for the Study of RNA-Protein Interactions: The IRE/IRP Example
Published on: December 3, 2014
Iron-dependent mechanisms in Acinetobacter baumannii: pathogenicity and resistance
Rong Zhang1,2, Dan Li1,2, Hong Fang2
1Department of Pulmonary and Critical Care Medicine, Southwest Medical University, Luzhou, China.
Abstract:
Acinetobacter baumannii is a Gram-negative opportunistic pathogen that poses a significant challenge in healthcare settings, particularly in ICUs, due to its MDR and high mortality rates, especially among critically ill coronavirus disease 2019 patients. Iron is crucial for the survival, growth and pathogenicity of A. baumannii, and the bacterium has developed multiple iron acquisition systems, including siderophore production, haem uptake and TonB-dependent transport mechanisms, to adapt to the iron-limited environment within the host. Although specific studies on A. baumannii are limited, mechanisms from other bacterial species suggest that similar iron acquisition strategies may play a key role in its virulence. Therapeutic approaches targeting these iron-dependent systems, such as the siderophore-conjugated cephalosporin cefiderocol, have shown potential in overcoming MDR A. baumannii infections. Additionally, strategies such as synthetic siderophores, TonB receptor inhibitors and iron chelators are under investigation to enhance treatment outcomes. Future research should prioritize validating these mechanisms in A. baumannii, advancing clinical trials for these therapies and exploring combination treatments to mitigate resistance and improve clinical outcomes in severely affected patients.
Insights
Acinetobacter baumannii uses iron acquisition systems for survival and virulence. Targeting these systems, like with cefiderocol, offers potential against multidrug-resistant infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- Acinetobacter baumannii is a Gram-negative opportunistic pathogen causing significant healthcare challenges, especially in ICUs.
- Multidrug resistance (MDR) and high mortality rates, particularly in critically ill COVID-19 patients, underscore the urgency of addressing A. baumannii infections.
Purpose of the Study:
- To explore the critical role of iron acquisition systems in A. baumannii survival, growth, and pathogenicity.
- To review potential therapeutic strategies targeting iron-dependent mechanisms to combat MDR A. baumannii.
Main Methods:
- Review of existing literature on bacterial iron acquisition mechanisms, extrapolating findings to A. baumannii.
- Analysis of therapeutic approaches targeting iron metabolism in bacteria, including siderophore-conjugated antibiotics and iron chelators.
Main Results:
- A. baumannii employs multiple iron acquisition systems (siderophore production, haem uptake, TonB-dependent transport) crucial for virulence.
- Therapeutic agents like cefiderocol show promise in treating MDR A. baumannii infections by targeting iron acquisition.
Conclusions:
- Iron acquisition pathways are key virulence factors in A. baumannii, presenting viable therapeutic targets.
- Further research and clinical trials are needed for novel strategies like synthetic siderophores and TonB receptor inhibitors to improve treatment outcomes.
More Related Videos
Related Concept Videos
Electron Transport Chain: Complex III and IV
Corrosion
The Electron Transport Chain
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Introduction to Mechanisms of Enzyme Catalysis
The Supercomplexes in the Crista Membrane

